News

Filter

Avanir Pharma files NDA for migraine drug AVP-825

30-01-2014

US drugmaker Avanir Pharmaceuticals has submitted a New Drug Application to the US Food and Drug Administration…

Avanir PharmaceuticalsAVP-825NeurologicalNorth AmericaPharmaceuticalRegulationUSA

Avanir Pharma patent settlement with Wockhardt

08-09-2013

USA-based Avanir Pharmaceuticals (Nasdaq: AVNR) has entered into a settlement agreement with the US unit…

Avanir PharmaceuticalsGenericsLegalNeurologicalNorth AmericaNuedextaPatentsPharmaceuticalWockhardt

Avanir Pharma settles Nuedexta patent litigation with Actavis

03-09-2013

USA-based Avanir Pharmaceuticals (Nasdaq: AVNR) says that it has entered into a settlement agreement…

ActavisAvanir PharmaceuticalsGenericsLegalNeurologicalNorth AmericaNuedextaPatentsPharmaceutical

Avanir agrees settlement with Sandoz over Nuedexta

14-08-2013

US drugmaker Avanir Pharmaceuticals (Nasdaq: AVNR) has entered into a settlement agreement with Swiss…

Avanir PharmaceuticalsGenericsLicensingNeurologicalNorth AmericaNuedextaPharmaceuticalSandoz

Avanir in up to $110 million deal with OptiNose for migraine product

03-07-2013

US drugmaker Avanir Pharmaceuticals (Nasdaq: AVNR) has entered into an exclusive North American license…

Avanir PharmaceuticalsLicensingNeurologicalNorth AmericaOptiNosePharmaceuticalsumatriptan

Avanir's Nuedexta approved for PBA in Europe

26-06-2013

Avanir PharmaceuticalsNeurologicalNuedextaPharmaceutical

Avanir sues Par and Actavis over Nuedexta patent infringement

12-08-2011

California, USA-based Avanir Pharmaceuticals (Nasdaq: AVNR) has filed law suits in the US District Court…

ActavisAvanir PharmaceuticalsGenericsLegalNeurologicalNorth AmericaNuedextaPar PharmaceuticalsPatentsPharmaceutical

Back to top